Clinical Indications for Coronary Artery Calcium Scoring in Asymptomatic Patients

Written by the imaging specialists who know coronary calcium scanning best, this SCCT consensus answers the question their colleagues kept asking: in a person with no symptoms, when is a calcium scan actually worth doing?

The answer it gives is precise. The sweet spot is the asymptomatic adult aged 40 to 75 sitting in the intermediate zone of estimated risk — roughly 5 to 20 percent over ten years — where the treatment decision is genuinely uncertain and a direct look at the artery can break the tie. The statement maps treatment to the result (zero, 1–99, 100–299, 300 and above), specifies sensible re-scanning intervals, and makes a striking claim backed by the data: of all the biomarkers studied, calcium scoring has the greatest power to reclassify a patient’s risk. It explicitly positions CAC as the corrective to a known flaw — the tendency of the Pooled Cohort Equations to overestimate risk in many people, leading to overtreatment.

The document is candid that it speaks from a particular vantage. As a statement from the imaging society, it is enthusiastic about the test; the more cautious USPSTF, weighing the same field, found the outcome evidence insufficient to recommend it broadly. The honest truth sits between them: CAC is excellent at reclassifying risk, but no randomized trial has yet proven that scanning-guided management saves lives.

We rate the evidence strong. For the specific job of resolving the ambiguous middle — treating those who need it, reassuring those who don’t — this is one of the clearest and most practical statements available.